Group One Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-33,800
Closed -$131K 8055
2023
Q2
$131K Sell
33,800
-211,900
-86% -$610K ﹤0.01% 4349
2023
Q1
$681K Buy
+245,700
New +$515K ﹤0.01% 2475
2022
Q2
Sell
-1,700
Closed -$7K 8262
2022
Q1
$7K Sell
1,700
-2,100
-55% -$8.62K ﹤0.01% 7302
2021
Q4
$20K Sell
3,800
-3,700
-49% -$19.8K ﹤0.01% 6984
2021
Q3
$46K Buy
+7,500
New +$59.8K ﹤0.01% 6604

Other funds holding NAUT

Group One Trading's NAUT Position: Q1 2026 in Review

Group One Trading sold out of Nautilus Biotechnolgy (NAUT) in Q1 2026, closing a stake of 3,880 shares — an estimated $9.53K sold.

Group One Trading first reported a position in NAUT in Q3 2021 and held it in 5 quarters. The position peaked at $415K in Q1 2023. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Group One Trading reported no remaining Nautilus Biotechnolgy position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,880 Nautilus Biotechnolgy shares in Q1 2026, an estimated $9.53K.
  • Group One Trading first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 5 quarters.
  • Group One Trading's Nautilus Biotechnolgy position peaked at $415K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.